Saliva May Be an Easier Alternative for Rapid COVID-19 Tests
A new study on rapid COVID-19 testing is investigating whether a saliva-based rapid antigen testing is more effective than the more common PCR tests.
Category: POC Rapid Assays
POC Rapid Assays
Latest
POC Rapid Assays
Latest
Partnership Facilitates COVID Testing Process for U.S. Travelers
ARCpoint Labs is utilizing its national network of diagnostic testing facilities to help travelers find convenient locations for COVID-19 testing.
POC Rapid Assays
Latest
LumiraDx Receives FDA EUA for its COVID-19 Antibody Test
LumiraDx has announced receiving FDA EUA for its SARS-CoV-2 Ab test, which is used to help identify an adaptive immune response to SARS-CoV-2.
Quidel QuickVue At-Home Covid-19 Test Receives EUA
The antigen test enables certain individuals to rapidly collect and test their samples at home without needing to send them to a laboratory for analysis.
Read More
LightDeck Diagnostics Awarded $5.65M to Develop a Covid-19 Rapid Antigen Test
These funds will enable the company to develop a point-of-care antigen test that delivers results in less than 6 minutes.
Read More
Abbott’s Covid-19 Antigen Test May Help with Faster Detection, Isolation, Per the CDC
A study from the CDC found that BinaxNOW catches most infectious cases but may miss nearly two-thirds of covid-19 infections in people without symptoms.
Read More
QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More
EUA for Quidel’s QuickVue SARS Rapid Antigen Test
The easy-to-use, visually read test could expand testing for covid-19 to diverse point-of-care locations.
Read More
New FDA Authorization for the BinaxNow Covid-19 Ag Card Home Test
Abbott and eMed expect to deliver and administer 30 million BinaxNow tests in the first quarter of 2021, with an additional 90 million in the second quarter.
Read More
FDA Authorizes First Covid-19 Test for Self-Testing at Home
The Lucira Covid-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single-use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes covid-19.
Read More
BARDA Further Funds Inflammatix ViraBac EZ Acute Infection Test
This additional BARDA funding supports a test designed to read the immune system and rapidly diagnose acute infection at the point of care.
Read More
FDA EUA for Quidel’s Rapid Antigen “ABC Test” for Influenza A and B and Covid-19
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read More
First POC Covid-19 Antibody Test Now Available
This test, distributed by Carolina Liquid Chemistries, is now authorized for use with fingerstick whole blood specimens at the point-of-care.
Read More
BD Rapid POC Covid-19 Antigen Test Gets CE Mark
The new BD covid-19 antigen test delivers results in 15 minutes on the portable BD Veritor Plus System.
Read More
Global Partnership to Offer 120 Million Covid-19 Rapid Tests for Low- and Middle-Income Countries
The rapid diagnostics from Abbott and SD Biosensor will enable expanded testing in countries that do not have extensive laboratory facilities.
Read More
Rapid Portable Covid-19 Test to Analyze Over 30 Samples Per Hour
Two versions of the covid-19 Antigen Test are scheduled for US launch in the fourth quarter: one for labs and one for point-of-care use.
Read More
FDA Authorizes First Covid-19 Diagnostic with Results Readable from a Card
Results from Abbott’s BinaxNow Covid-19 Ag Card rapid test can be read directly from the testing card, a device similar to some pregnancy tests.
Read MoreUCI Develops Low-Cost, Accurate Covid-19 Antibody Detection Platform
Using blood from a finger prick, the test probes hundreds of antibody responses to 14 respiratory viruses, including the cause of covid-19, in 2 to 4 hours.
Read More